By Fiona Chin N.D. 
Mitochondrial peptides are transforming the way we approach kidney health and chronic kidney disease (CKD). These cutting-edge molecules play a vital role in slowing kidney aging, supporting mitochondrial repair, and enhancing cellular energy production, key factors in preventing kidney decline.
In this episode, Alex Kikel joins us to explore the science behind mitochondrial and bioregulator peptides, including SS-31, VD-11, SLU-PP-332, and Klotho, and how they work to restore mitochondrial function, improve kidney regeneration, and support long-term kidney repair.
Discover how peptide therapy for mitochondria is shaping the future of chronic disease treatment, from reducing inflammation and oxidative stress to enhancing cellular resilience and reversing aspects of kidney aging.
We also dive into:
✅ The connection between mitochondrial health and kidney function
✅ How bioregulator peptides signal repair at the genetic level
✅ The emerging role of mitochondrial-focused peptide therapy in CKD and metabolic health
✅ The potential of regenerative molecules to restore biological youth
If you’re interested in the science of peptides for kidneys, mitochondrial longevity, and bioregulator-based repair, this is a must-watch for practitioners and anyone seeking deeper insight into the next frontier of kidney and metabolic health.
00:00 Intro
00:17 Alex Kikel Introduction
02:41 VD11 & Emerging Therapeutic Molecules
08:05 SLU & Its Therapeutic Potential
16:32 Klotho: The Therapeutic Molecule
31:05 SS31 Peptide: Mechanisms, Dosage & Applications
42:11 The Future of CKD and Mitochondrial Therapies
54:11 Final Thoughts: Staying Curious and Open-Minded
55:36 Outro
